Recipharm AB engages in the provision of pharmaceutical development services. The firm manufactures pharmaceuticals in various dosage forms; as well as produces clinical trial material including API and pharmaceutical product development. It operates through the business segments: Manufacturing Service Sterile Liquids (MFG-SL); Manufacturing Services Solids (MFGSO); Development and Technology (D&T); and Others. The MFG-SL segment produces sterile liquids including lyophilisation. The MFGSO segment offers solid dose, semi solid, non sterile liquids, and other. The D&T segment includes development services to pharmaceutical companies and sales through distributors of own products. The Others segment involves other activities. The company was founded by Lars Rickard Backsell and Thomas Bengt Eldered in 1995 and is headquartered in Jordbro, Sweden.